监督下运动治疗对比无运动治疗逆转前列腺癌患者雄激素剥夺治疗虚弱效应的系统综述与荟萃分析
结果显示监督下运动治疗在疾病特异性生活质量和步行表现上均有临床相关改善,标准化均数差分别为0.43(95%CI 0.29,0.58)和-0.41(95%CI -0.60,-0.22),证据确定性为中等。
要点
- 监督下运动治疗可改善ADT患者的疾病特异性生活质量和步行表现。
- 效应量分别为SMD 0.43和-0.41,证据确定性中等。
- 结果适用于所有接受ADT的前列腺癌患者,不受肿瘤分期限制。
核心结论
- 中等质量证据表明监督下运动治疗在改善ADT患者的疾病特异性生活质量和步行表现方面可能优于无运动治疗。
- 结果支持对接受ADT患者进行监督下运动治疗的强烈推荐以管理副作用。
研究设计与样本
- 系统综述与荟萃分析,检索PubMed/Medline、Embase、Cochrane Library、Cinahl和Pedro,最后检索时间为2021年6月。
- 两名独立评审者提取数据,使用Cochrane偏倚风险工具评估偏倚风险,并采用GRADE方法评价证据确定性。
主要发现
- 与无运动治疗相比,监督下运动治疗在疾病特异性生活质量上显示临床相关改善,标准化均数差为0.43(95%CI 0.29,0.58)。
- 在步行表现上显示临床相关改善,标准化均数差为-0.41(95%CI -0.60,-0.22)。
- 总体证据确定性为中等,因存在严重偏倚风险。
关键数值与推荐
- 疾病特异性生活质量的标准化均数差为0.43(95%CI 0.29,0.58)。
- 步行表现的标准化均数差为-0.41(95%CI -0.60,-0.22)。
临床怎么用
- 对于接受ADT的前列腺癌患者,可推荐监督下运动治疗以改善疾病特异性生活质量和步行表现。
- 该推荐适用于所有接受ADT的患者, regardless of cancer stage。
局限性
- 总体证据确定性为中等,因存在严重偏倚风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Androgen deprivation therapy (ADT) in patients with prostate cancer can have several debilitating side effects. Supervised exercise is recommended to ameliorate these negative effects. OBJECTIVE: To systematically evaluate the effect of supervised exercise therapy compared to no exercise therapy in patients with prostate cancer undergoing ADT, primarily according to the patient critical outcomes, 'disease-specific quality of life' and 'walking performance' measured at end of treatment. METHODS: We searched PubMed/Medline, Embase, Cochrane Library, Cinahl and Pedro, to identify randomised controlled trials (RCTs), which investigated the effect of supervised exercise therapy compared to no exercise therapy in patients with prostate cancer receiving ADT, last search: June 2021. Two independent reviewers extracted data, and assessed risk of bias using Cochrane Risk of Bias Tool and evaluated the certainty of evidence using the GRADE-method. RESULTS: Eigthteen RCTs (n = 1477) comprised patients with prostate cancer stages T1-T4 were included in the meta-analyses. Compared to no exercise therapy, supervised exercise therapy showed clinically relevant improvements in 'disease-specific quality of life' and 'walking performance'. The standardised mean differences were 0.43 (95% confidence interval (CI): 0.29, 0.58) and -0.41 (95% CI: -0.60, -0.22), respectively. The overall certainty of evidence was moderate due to serious risk of bias. CONCLUSIONS: Evidence of moderate quality shows that supervised exercise therapy probably is superior to no exercise therapy in improving 'disease-specific quality of life' and 'walking performance' in patients with prostate cancer undergoing ADT. The results apply to all patients receiving androgen deprivation therapy regardless of cancer stage. The results support a strong recommendation for supervised exercise therapy for managing side effects in this population. PROTOCOL REGISTRATION: NKR-38-Focused-questions-PICOs-for-updating1.ashx (sst.dk).
引用
- Ussing A, Mikkelsen MK, Villumsen BR, et al. Supervised exercise therapy compared with no exercise therapy to reverse debilitating effects of androgen deprivation therapy in patients with prostate cancer: a systematic review and meta-analysis. Prostate Cancer Prostatic Dis. 2021. PMID: 34489536. doi:10.1038/s41391-021-00450-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。